Analysts expect that Acadia Healthcare Company Inc (NASDAQ:ACHC) will post $0.54 earnings per share (EPS) for the current quarter, Zacks reports. Seven analysts have provided estimates for Acadia Healthcare’s earnings, with the highest EPS estimate coming in at $0.58 and the lowest estimate coming in at $0.47. Acadia Healthcare posted earnings of $0.55 per share during the same quarter last year, which suggests a negative year-over-year growth rate of 1.8%. The business is expected to issue its next quarterly earnings results on Monday, November 4th.
On average, analysts expect that Acadia Healthcare will report full-year earnings of $2.14 per share for the current fiscal year, with EPS estimates ranging from $2.02 to $2.23. For the next fiscal year, analysts forecast that the business will report earnings of $2.44 per share, with EPS estimates ranging from $2.03 to $2.97. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow Acadia Healthcare.
Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Tuesday, July 30th. The company reported $0.61 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.59 by $0.02. The business had revenue of $789.00 million for the quarter, compared to analyst estimates of $795.31 million. Acadia Healthcare had a negative net margin of 6.80% and a positive return on equity of 7.20%. The business’s quarterly revenue was up 3.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.70 EPS.
A number of equities analysts have commented on ACHC shares. Raymond James lowered shares of Acadia Healthcare from a “strong-buy” rating to an “outperform” rating and set a $45.00 price objective on the stock. in a report on Wednesday, July 31st. Zacks Investment Research lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating and set a $31.00 price objective on the stock. in a report on Wednesday, August 7th. Mizuho set a $30.00 price objective on shares of Acadia Healthcare and gave the stock a “hold” rating in a report on Friday, May 31st. TheStreet upgraded shares of Acadia Healthcare from a “d+” rating to a “c” rating in a report on Monday, June 17th. Finally, UBS Group cut their price objective on shares of Acadia Healthcare from $30.00 to $29.00 and set a “neutral” rating on the stock in a report on Friday, September 6th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $36.00.
In other news, CEO Debra K. Osteen acquired 20,000 shares of the business’s stock in a transaction on Thursday, September 5th. The shares were purchased at an average price of $26.53 per share, for a total transaction of $530,600.00. Following the acquisition, the chief executive officer now directly owns 117,178 shares of the company’s stock, valued at approximately $3,108,732.34. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 2.60% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. Nomura Holdings Inc. acquired a new stake in shares of Acadia Healthcare in the 2nd quarter valued at about $271,000. Royal Bank of Canada grew its position in Acadia Healthcare by 3.1% in the 2nd quarter. Royal Bank of Canada now owns 390,923 shares of the company’s stock worth $13,661,000 after purchasing an additional 11,914 shares during the last quarter. Concourse Capital Management LLC grew its position in Acadia Healthcare by 9.3% in the 2nd quarter. Concourse Capital Management LLC now owns 132,570 shares of the company’s stock worth $4,633,000 after purchasing an additional 11,250 shares during the last quarter. Eaton Vance Management grew its position in Acadia Healthcare by 58.6% in the 2nd quarter. Eaton Vance Management now owns 108,311 shares of the company’s stock worth $3,785,000 after purchasing an additional 40,000 shares during the last quarter. Finally, Nuveen Asset Management LLC bought a new position in Acadia Healthcare in the 2nd quarter worth about $8,508,000.
ACHC stock traded up $0.46 during trading on Friday, reaching $32.04. The stock had a trading volume of 117,317 shares, compared to its average volume of 762,771. Acadia Healthcare has a 1-year low of $24.27 and a 1-year high of $45.35. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 1.53. The company has a market capitalization of $2.69 billion, a P/E ratio of 14.30, a PEG ratio of 1.34 and a beta of 0.71. The firm has a fifty day moving average price of $28.50 and a 200 day moving average price of $30.94.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
See Also: P/E Growth (PEG)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.